EPIC | EAH |
Sector | Pharma and Biotech |
ISIN | GB0032036807 |
Market Sector | AIM |
Market Segment | ASX1 |
Main Indices | FTSE AIM All-Share |
Country of register | Great Britain |
Currency | British Pound |
Market Cap | £79.94m |
NMS | 1,500 |
Shares in issue | 67.74m |
Date Listed | 26-Sep-1995 |
Currency | UK Pounds |
Share Price | 118.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 122.00 |
52 Week Low | 84.00 |
Volume | 88,184 |
Shares Issued | 67.74m |
Market Cap | £79.94m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 23-Sep-21 | 26-Sep-19 |
Paid | 22-Oct-21 | 16-Oct-19 |
Amount | 1.00p | 7.04p |
Time | Volume / Share Price |
12:56 | 40,000 @ 116.00p |
12:56 | 40,000 @ 116.08p |
15:19 | 2,500 @ 117.25p |
14:58 | 1,418 @ 116.00p |
11:14 | 44 @ 116.00p |
CFO | Christopher Wilks |
CEO | David Hallas |
You are here: research